Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 2
2015 6
2016 6
2017 8
2018 8
2019 8
2020 18
2021 13
2022 17
2023 27
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jae hoon yoo (8 results)?
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, Monroy J, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Falsey AR, Walsh EE, Dhar R, Wilson L, Du J, Ghaswalla P, Kapoor A, Lan L, Mehta S, Mithani R, Panozzo CA, Simorellis AK, Kuter BJ, Schödel F, Huang W, Reuter C, Slobod K, Stoszek SK, Shaw CA, Miller JM, Das R, Chen GL; ConquerRSV Study Group. Wilson E, et al. N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079. N Engl J Med. 2023. PMID: 38091530 Clinical Trial.
Mycobacterium abscessus glossitis.
Ko JH, Kang CI, Cho SY, Ha YE, Lee NY, Kim SJ, Chung DR, Peck KR, Song JH. Ko JH, et al. Lancet Infect Dis. 2017 Oct;17(10):1098. doi: 10.1016/S1473-3099(17)30525-X. Lancet Infect Dis. 2017. PMID: 28948933 No abstract available.
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
Yang J, Won G, Baek JY, Lee YH, Kim H, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Lee KW, Park JB, Yoon SE, Kim SJ, Kim WS, Yim MS, Kim K, Hyeon S, Kim BC, Lee YK, Ko JH. Yang J, et al. Among authors: ko jh. Front Immunol. 2023 Mar 2;14:1139980. doi: 10.3389/fimmu.2023.1139980. eCollection 2023. Front Immunol. 2023. PMID: 36936968 Free PMC article.
Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.
Kim H, Jang YR, Lee JY, Ko JH, Lee JY, Cho S, Lee YD, Song J, Hyun M, Kim HA, Hwang S, Ryou S, Na YJ, Lee JY, Lee C, Lee NY, Shin S, Kwon KT, Kim JY, Peck KR. Kim H, et al. Among authors: ko jh. Front Cell Infect Microbiol. 2023 May 15;13:1192512. doi: 10.3389/fcimb.2023.1192512. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37256107 Free PMC article.
Impact of vancomycin resistance in Enterococcus faecium bloodstream infection on mortality: A retrospective analysis of nationwide surveillance data.
Huh K, Chung DR, Ha YE, Ko JH, Huh HJ, Lee NY, Cho SY, Kang CI, Peck KR, Song JH; Korean Antimicrobial Resistance Surveillance Network (KARS-Net) investigators. Huh K, et al. Among authors: ko jh. Int J Infect Dis. 2023 Sep;134:8-14. doi: 10.1016/j.ijid.2023.04.411. Epub 2023 May 11. Int J Infect Dis. 2023. PMID: 37172775 Free article.
Severe Thrombocytopenia in a Patient with COVID-19.
Nham E, Ko JH, Jeong BH, Huh K, Cho SY, Kang CI, Chung DR, Peck KR. Nham E, et al. Among authors: ko jh. Infect Chemother. 2020 Sep;52(3):410-414. doi: 10.3947/ic.2020.52.3.410. Epub 2020 Jul 13. Infect Chemother. 2020. PMID: 32342677 Free PMC article.
103 results